103 related articles for article (PubMed ID: 9390640)
1. Energy-dependent expression of platelet-von Willebrand factor on the surface of unstimulated and stimulated platelets.
Parker RI; Gralnick HR
J Lab Clin Med; 1997 Nov; 130(5):520-9. PubMed ID: 9390640
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin on platelet-von Willebrand factor surface expression on thrombin and ADP-stimulated platelets.
Parker RI; Gralnick HR
Blood; 1989 Nov; 74(6):2016-21. PubMed ID: 2529923
[TBL] [Abstract][Full Text] [Related]
3. ATP augments von Willebrand factor-dependent shear-induced platelet aggregation through Ca2+-calmodulin and myosin light chain kinase activation.
Oury C; Sticker E; Cornelissen H; De Vos R; Vermylen J; Hoylaerts MF
J Biol Chem; 2004 Jun; 279(25):26266-73. PubMed ID: 15087444
[TBL] [Abstract][Full Text] [Related]
4. Effect of calcium on the availability of platelet von Willebrand factor.
Parker RI; Rick ME; Gralnick HR
J Lab Clin Med; 1985 Sep; 106(3):336-42. PubMed ID: 3161964
[TBL] [Abstract][Full Text] [Related]
5. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
Miller JL; Kupinski JM; Castella A; Ruggeri ZM
J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
[TBL] [Abstract][Full Text] [Related]
6. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
[TBL] [Abstract][Full Text] [Related]
7. Quantification of energy consumption in platelets during thrombin-induced aggregation and secretion. Tight coupling between platelet responses and the increment in energy consumption.
Verhoeven AJ; Mommersteeg ME; Akkerman JW
Biochem J; 1984 Aug; 221(3):777-87. PubMed ID: 6236799
[TBL] [Abstract][Full Text] [Related]
8. Thrombin receptor occupancy modulates aggregation efficiency and platelet surface expression of vWF and thrombospondin at low thrombin concentrations.
Kasirer-Friede A; Legrand C; Frojmovic MM
Thromb Haemost; 1999 Jun; 81(6):967-75. PubMed ID: 10404777
[TBL] [Abstract][Full Text] [Related]
9. Characterization of calcium-dependent binding of endogenous factor VIII/von Willebrand factor to surface activated platelets.
Furby FH; Berndt MC; Castaldi PA; Koutts J
Thromb Res; 1984 Sep; 35(5):501-11. PubMed ID: 6435280
[TBL] [Abstract][Full Text] [Related]
10. Asialo von Willebrand factor binding to and aggregation of platelets: effects of inhibitors of platelet metabolism and function.
Williams SB; McKeown LP; Gralnick HR
J Lab Clin Med; 1987 May; 109(5):560-5. PubMed ID: 2437231
[TBL] [Abstract][Full Text] [Related]
11. The relationship of von Willebrand factor binding to activated platelets from healthy neonates and adults.
Schmugge M; Rand ML; Bang KW; Mody M; Dunn MS; Amankwah KS; Blanchette VS; Freedman J
Pediatr Res; 2003 Oct; 54(4):474-9. PubMed ID: 12815111
[TBL] [Abstract][Full Text] [Related]
12. Close correlation between platelet responses and adenylate energy charge during transient substrate depletion.
Akkerman JW; Gorter G; Soons H; Holmsen H
Biochim Biophys Acta; 1983 Oct; 760(1):34-41. PubMed ID: 6615883
[TBL] [Abstract][Full Text] [Related]
13. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
Holmsen H; Setkowsky CA; Day HJ
Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
[TBL] [Abstract][Full Text] [Related]
14. Adenine nucleotide metabolism of blood platelets. IX. Time course of secretion and changes in energy metabolism in thrombin-treated platelets.
Fukami MH; Holmsen H; Salganicoff L
Biochim Biophys Acta; 1976 Oct; 444(3):633-43. PubMed ID: 10970
[TBL] [Abstract][Full Text] [Related]
15. Platelet--von Willebrand factor interactions in type IIB von Willebrand's disease.
Holmberg L; Kristoffersson AC; Lamme S; Nilsson IM; Awidi A; Solum NO
Scand J Haematol; 1985 Sep; 35(3):305-14. PubMed ID: 3877338
[TBL] [Abstract][Full Text] [Related]
16. Independent modulation of von Willebrand factor and fibrinogen binding to the platelet membrane glycoprotein IIb/IIIa complex as demonstrated by monoclonal antibody.
Lombardo VT; Hodson E; Roberts JR; Kunicki TJ; Zimmerman TS; Ruggeri ZM
J Clin Invest; 1985 Nov; 76(5):1950-8. PubMed ID: 2414325
[TBL] [Abstract][Full Text] [Related]
17. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
Lückhoff A; Bohnert M; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
[TBL] [Abstract][Full Text] [Related]
18. Platelet activation and alpha granule secretion in type IIB von Willebrand's disease.
Gralnick HR; Williams S; McKeown LP; Connaghan G; Shafer B; Hansmann K; Magruder L; Vail M
Br J Haematol; 1991 Dec; 79(4):618-23. PubMed ID: 1722992
[TBL] [Abstract][Full Text] [Related]
19. Metabolic plasticity in resting and thrombin activated platelets.
Ravi S; Chacko B; Sawada H; Kramer PA; Johnson MS; Benavides GA; O'Donnell V; Marques MB; Darley-Usmar VM
PLoS One; 2015; 10(4):e0123597. PubMed ID: 25875958
[TBL] [Abstract][Full Text] [Related]
20. Distinct abnormalities in the interaction of purified types IIA and IIB von Willebrand factor with the two platelet binding sites, glycoprotein complexes Ib-IX and IIb-IIIa.
De Marco L; Mazzucato M; De Roia D; Casonato A; Federici AB; Girolami A; Ruggeri ZM
J Clin Invest; 1990 Sep; 86(3):785-92. PubMed ID: 2394830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
